GeoVax (GOVX) Monkeypox (MPOX) PowerPoint.
In a recent press release, GeoVax shared progress on their MPOX Vaccine and published a PowerPoint related to the their planned upcoming MonkeyPox trial..
The...
GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!
What an Entertaining Week!
..and it's only Thursday.
LIVE QUOTE
(MAY 18TH)
(MAY 21ST)
So Where Does That Leave us Today?
Yes, it was a pleasant surprise to see GeoVax...
Cabaletta (CABA) Surges 44% on Massive Volume Spike.
Biotech 12 Pack Off to Nice Start..
Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April!
Biotech Stock Review is...
GeoVax (GOVX) Surges 51% on Massive Volume Spike.
MonkeyPox and Gedeptin Related News Spark New Investor Interest.
MARKET BRIEF
On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...
Paving Past Obstacles on the Path to US Biosecurity
GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China.
National biosecurity has become a frequent topic of conversation in...
GeoVax (GOVX) Reports 2025 Year-End Financial Results and Provides Business Update
LIVE QUOTE
Pivotal Phase 3 Trial for GEO-MVA (Mpox/Smallpox Vaccine)
Scheduled to Initiate During the Second Half of This Year
ATLANTA, GA - April 15, 2026 (NEWMEDIAWIRE)...
Danger Will Robinson: the NIPAH Virus with a 40-75% Death Rate Lurks.
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Click to...
Report: AI Powered Review on GeoVax (GOVX) $1.15
In our view, a research report is designed to gather information on publicly traded companies from press releases, management presentations (including power points), SEC...
Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Added to Watch List.
Biotech 12 Pack Watch List to be Released.
Cabaletta (CABA) $3.07, GeoVax (GOVX) $1.14, PolyPid (PYPD) $4.68, Replimune (REPL) $2.17.
In 2020, we Released the "Biotech...
Replimune (REPL). $269 Million in Cash and a $178 Million Market Cap. What are...
Adding Replimune to 2026 Watch List @ $2.17
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but...
Latest article
We’re Up 360% in Six Weeks. Replimune (REPL).
That's a Gain of $604 Million, and That Ain't Bad!
Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...
GeoVax (GOVX) Conference Call and Transcript.
Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah.
Guess what we'll choose to do?
We have no...
Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.
Top Ranked Defense, Government and Enterprise Contractor
Trying to Break Over $0.06.
We are still sitting on the edge of our seat waiting for contract news,...
